Zacks7d agobearish
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallTransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
307last 24h
1812last 7d
321🟢 bullish (7d)
187🔴 bearish (7d)
129publishers
Zacks7d agobearish
TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesTransMedics (TMDX) delivered earnings and revenue surprises of -51.46% and -0.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?